Tirzepatide is a once-weekly injection available as two brands: Zepbound (for weight loss, weight management, and obstructive sleep apnea) and Mounjaro (for type 2 diabetes)
Treating one without addressing the other produces incomplete results
However, the role of the SEMA3E/PLXND1/NRP1 signalling pathway in pancreatic islet function remains to be established
This test analyzes 14 metabolic pathways and 150+ genetic insights, including variants in GLP1R, GIPR, FTO, and MC4R genes that influence how your body responds to peptide therapies
J Biol Chem 287(40):3388333896 Hardy AB, Prentice KJ, Froese S, Liu Y, Andrews GK, Wheeler MB (2015) Zip4 mediated zinc influx stimulates insulin secretion in pancreatic beta cells
Wegovy 7.2mg vs Other Weight Loss Treatments Wegovy 7.2mg Semaglutide Once weekly Up to 21% weight loss From 279 per month Wegovy 2.4mg Semaglutide Once weekly Up to 17% weight loss From 170 per month Mounjaro 15mg Tirzepatide Once weekly Up to 22.5% weight loss From 175 per month Saxenda Liraglutide Daily injection Up to 8% weight loss From 250 per month Wegovy 7.2mg delivers nearly the same results as Mounjaro but may cost less
